甘露醇市场规模、份额及成长分析（按形态、应用和地区划分）－2026-2033年产业预测

预计到 2024 年，全球甘露醇市场规模将达到 4.7969 亿美元，到 2025 年将达到 5.0655 亿美元，到 2033 年将达到 7.8331 亿美元，在预测期（2026-2033 年）内复合年增长率为 5.6%。

由于人口结构和生活方式的改变，以及某些疾病的流行，全球甘露醇市场预计将持续成长。甘露醇在製药业中被用作药物製剂的添加剂，并应用于肾臟、脑部和心臟疾病的治疗，以及作为片剂生产的填充剂，这些都凸显了其重要性。甘露醇具有高水溶性、低塑性和低湿度敏感性等特性，使其成为製造商的首选原料。此外，消费者对无糖产品的需求不断增长，尤其是在註重健康的消费者和糖尿病患者中，预计将进一步推动市场成长。利用乳酸菌进行合成製程的创新可望实现成本效益高且永续性的生产，为各种医疗应用带来新的机会，并持续提升市场潜力。

全球甘露醇市场驱动因素

全球对甘露醇的需求主要受其作为活性药物成分（API）在多种治疗糖尿病、心臟病和癌症等慢性疾病的药物中的应用影响。随着这些疾病在全球发病率的持续上升，对有效治疗方法的需求日益增长，甘露醇在製药业的重要性也随之提升。其在药物製剂中的应用不仅凸显了其治疗价值，也强调了其对改善患者预后的显着贡献。因此，越来越多的患者寻求有效控制这些慢性疾病，推动了甘露醇市场的成长，也反映了其在现代医学中的关键作用。

限制全球甘露醇市场的因素

全球甘露醇市场面临来自各种低热量甜味剂（例如甜菊糖、阿斯巴甜和蔗糖素）的激烈竞争。这些替代甜味剂的存在可能会降低甘露醇的吸引力，尤其是在食品饮料行业，导致需求下降。随着消费者越来越多地转向这些具有相似甜度和多种健康益处的替代品，这种竞争格局可能会阻碍製造商投资甘露醇生产。因此，消费者对其他甜味剂的持续偏好对甘露醇市场的成长和扩张构成了重大阻碍因素。

全球甘露醇市场趋势

全球甘露醇市场需求显着成长，主要驱动因素是其作为製药业关键辅料的作用，能够提高药物溶解度和生物利用度。随着慢性病发病率的持续上升，製药业不断创新以开发更有效的治疗方法，甘露醇的应用也日益广泛。此外，对先进药物递送系统的日益关注以及对符合严格监管标准的高品质辅料的需求，进一步推动了这一趋势。因此，在不断增长的医疗需求和不断发展的製药应用的双重驱动下，甘露醇市场正经历强劲成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管环境

全球甘露醇市场规模（依形态及复合年增长率划分）（2026-2033 年）

• 粉末
• 颗粒状

全球甘露醇市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 食品工业
• 製药
• 工业的
• 界面活性剂
• 个人护理
• 其他的

全球甘露醇市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Roquette Freres（France）
• Cargill, Incorporated（United States）
• Ingredion Incorporated（United States）
• SPI Pharma（United States）
• Shijiazhuang Huaxu Pharmaceutical Co., Ltd.（China）
• Qingdao Bright Moon Seaweed Group Co., Ltd.（China）
• Singsino Group Ltd.（China）
• Shandong Lianmeng International Trade Co., Ltd.（China）
• Merck KGaA（Germany）
• Pfizer Inc.（United States）
• DuPont de Nemours, Inc.（United States）
• Archer Daniels Midland Company（United States）
• Tate & Lyle PLC（United Kingdom）
• Mitsubishi Shoji Foodtech Co., Ltd.（Japan）
• Hebei Huaxu Pharmaceutical Co., Ltd.（China）
• Akhil Healthcare（India）
• Spectrum Chemical Manufacturing Corp.（United States）
• Caldic BV（Netherlands）
• Evonik Industries AG（Germany）
• Jungbunzlauer Suisse AG（Switzerland）

结论与建议

Global Mannitol Market size was valued at USD 479.69 Million in 2024 and is poised to grow from USD 506.55 Million in 2025 to USD 783.31 Million by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The global mannitol market is poised for expansion, driven by demographic shifts, lifestyle changes, and the prevalence of certain medical conditions. Its applications in the pharmaceutical industry as an excipient for drug formulation and treatment of kidney, brain, and heart disorders, along with its use as a bulking agent in tableting, underscore its significance. Factors such as high water solubility, low moldability, and minimal humidity sensitivity make mannitol a preferred choice among manufacturers. Additionally, the rising demand for sugar-free products, especially among health-conscious consumers and diabetics, is expected to further propel market growth. Innovations in synthesis processes utilizing lactic acid bacteria promise cost-effective production and sustainability, offering new opportunities across various healthcare applications and enhancing market potential continuously.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mannitol market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mannitol Market Segments Analysis

Global Mannitol Market is segmented by Form, Application and region. Based on Form, the market is segmented into Powder and Granular. Based on Application, the market is segmented into Food Industry, Pharmaceuticals, Industrial, Surfactants, Personal Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mannitol Market

The global demand for mannitol is significantly influenced by its role as an active pharmaceutical ingredient (API) in various medications targeting chronic conditions, including diabetes, heart disease, and cancer. As the incidence of these diseases continues to rise across the globe, the need for effective treatments enhances the importance of mannitol in the pharmaceutical industry. Its utilization in drug formulations not only underscores its therapeutic value but also emphasizes its critical contribution to improving patient outcomes. Consequently, the expanding patient population seeking effective management of these chronic illnesses fuels the growth of the mannitol market, reflecting its essential role in modern healthcare.

Restraints in the Global Mannitol Market

The global mannitol market encounters significant challenges due to competition from various low-calorie sweeteners, including stevia, aspartame, and sucralose. The presence of these alternative sweetening agents can diminish the appeal of mannitol, leading to a potential decline in its demand, particularly within the food and beverage sector. This competitive landscape may deter manufacturers from investing in mannitol production, as consumers increasingly turn to these alternatives that offer similar sweetness profiles with varying health benefits. Consequently, the ongoing preference for other sweeteners poses a considerable restraint on the growth and expansion of the mannitol market.

Market Trends of the Global Mannitol Market

The Global Mannitol market is experiencing a pronounced surge in demand, primarily driven by its pivotal role in the pharmaceutical industry as a vital excipient that enhances drug solubility and bioavailability. As chronic diseases continue to rise and the pharmaceutical sector innovates to develop more effective therapeutic formulations, the utilization of mannitol is becoming increasingly prominent. This trend is further bolstered by the growing emphasis on advanced drug delivery systems and the need for high-quality excipients that meet stringent regulatory standards. Consequently, the market is witnessing robust growth, fueled by both rising healthcare needs and the evolution of pharmaceutical applications.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Mannitol Market Size by Form & CAGR (2026-2033)

• Market Overview
• Powder
• Granular

Global Mannitol Market Size by Application & CAGR (2026-2033)

• Market Overview
• Food Industry
• Pharmaceuticals
• Industrial
• Surfactants
• Personal Care
• Others

Global Mannitol Market Size & CAGR (2026-2033)

• North America (Form, Application)
  • US
  • Canada
• Europe (Form, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Form, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Form, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Form, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cargill, Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ingredion Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPI Pharma (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shijiazhuang Huaxu Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qingdao Bright Moon Seaweed Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Singsino Group Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Lianmeng International Trade Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont de Nemours, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Archer Daniels Midland Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tate & Lyle PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Shoji Foodtech Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hebei Huaxu Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akhil Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Chemical Manufacturing Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caldic B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jungbunzlauer Suisse AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations